Growth predictors and prognosis of small abdominal aortic aneurysms
- PMID: 18440183
- DOI: 10.1016/j.jvs.2008.01.041
Growth predictors and prognosis of small abdominal aortic aneurysms
Abstract
Objective: Evidence regarding the influence of cardiovascular risk factors, comorbidities, and patient characteristics on the growth of small abdominal aortic aneurysms (AAA) is limited. We assessed, in an observational cohort study, rupture rates, risks of mortality, and the effects of cardiovascular risk factors and patient demographics on growth rates of small AAAs.
Methods: Between September 1996 and January 2005, 5057 patients with manifest arterial vascular disease or cardiovascular risk factors were included in the Second Manifestation of ARTerial disease (SMART) study. Measurements of the abdominal aortic diameter were performed in all patients. All patients with an initial AAA diameter between 30 and 55 mm were selected for this study. All AAA measurements during follow-up until August 2007 were collected. Multivariate regression analysis was performed to calculate the effects of demographic patient characteristics, initial AAA diameter, and cardiovascular risk factors on AAA growth.
Results: Included were 230 patients, with a mean age of 66 years and 90% were male. Seven AAA ruptures (six fatal) occurred in 755 patient years of follow-up (rupture rate 0.9% per patient-year). In 147 patients, AAA measurements were performed for a period of more than 6 months. The median follow-up time was 3.3 years (mean 4.0, range 0.5 to 11.1 years, standard deviation (SD) 2.5). Mean AAA diameter was 38.8 mm (SD 6.8) and mean expansion rate 2.5 mm/y. Patients using lipid-lowering drugs had a 1.2 mm/y (95% confidence interval [CI] -2.34 to -0.060 mm/y) lower AAA growth rate compared to nonusers of these drugs. Initial AAA diameter was associated with a 0.09 mm/y (95% CI 0.01 to 0.18 mm/y) higher growth rate per millimetre increase of the diameter. No other factors, including blood lipid values, were independently associated with AAA growth.
Conclusions: Lipid-lowering drug treatment and initial AAA diameter appear to be independently associated with lower AAA growth rates. The risk of rupture of these small abdominal aortic aneurysms was low, which pleads for watchful waiting.
Comment in
-
Regarding "Growth predictors and prognosis of small abdominal aortic aneurysms".J Vasc Surg. 2008 Oct;48(4):1067; author reply 1067. doi: 10.1016/j.jvs.2008.06.047. J Vasc Surg. 2008. PMID: 18992443 No abstract available.
-
Regarding "Growth predictors and prognosis of small abdominal aortic aneurysms".J Vasc Surg. 2008 Dec;48(6):1638; author reply 1638-9. doi: 10.1016/j.jvs.2008.07.065. J Vasc Surg. 2008. PMID: 19118750 No abstract available.
Similar articles
-
EVAR may reduce the risk of aneurysm rupture despite persisting type Ia endoleaks.J Endovasc Ther. 2011 Oct;18(5):676-82. doi: 10.1583/11-3432.1. J Endovasc Ther. 2011. PMID: 21992639
-
Incidence, follow-up, and outcomes of incidental abdominal aortic aneurysms.J Vasc Surg. 2010 Aug;52(2):282-9.e1-2. doi: 10.1016/j.jvs.2010.03.006. Epub 2010 Jun 11. J Vasc Surg. 2010. PMID: 20541348
-
Hyperhomocysteinaemia is associated with the rate of abdominal aortic aneurysm expansion.Eur J Vasc Endovasc Surg. 2007 Apr;33(4):391-4; discussion 395-6. doi: 10.1016/j.ejvs.2006.10.022. Epub 2006 Dec 11. Eur J Vasc Endovasc Surg. 2007. PMID: 17164089
-
The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms.J Cardiovasc Surg (Torino). 2009 Oct;50(5):599-609. J Cardiovasc Surg (Torino). 2009. PMID: 19741575 Review.
-
Pharmacological therapy for patients with abdominal aortic aneurysm.Expert Rev Cardiovasc Ther. 2009 Aug;7(8):999-1009. doi: 10.1586/erc.09.56. Expert Rev Cardiovasc Ther. 2009. PMID: 19673677 Review.
Cited by
-
Hemoglobin homeostasis in abdominal aortic aneurysm: diagnostic and prognostic potential of hemoglobin/heme and scavenger molecules.BMC Cardiovasc Disord. 2024 Aug 27;24(1):452. doi: 10.1186/s12872-024-04131-3. BMC Cardiovasc Disord. 2024. PMID: 39192217 Free PMC article.
-
What is the relationship between ¹⁸F-FDG aortic aneurysm uptake on PET/CT and future growth rate?Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1493-9. doi: 10.1007/s00259-011-1799-8. Epub 2011 Apr 6. Eur J Nucl Med Mol Imaging. 2011. PMID: 21468762 Clinical Trial.
-
A multi-locus genetic risk score for abdominal aortic aneurysm.Atherosclerosis. 2016 Mar;246:274-9. doi: 10.1016/j.atherosclerosis.2015.12.031. Epub 2016 Jan 5. Atherosclerosis. 2016. PMID: 26820802 Free PMC article.
-
Atorvastatin and growth, rupture of small unruptured intracranial aneurysm: results of a prospective cohort study.Ther Adv Neurol Disord. 2021 Apr 9;14:1756286420987939. doi: 10.1177/1756286420987939. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 33953800 Free PMC article.
-
Statins and subarachnoid hemorrhage in Medicare patients with unruptured cerebral aneurysms.Int J Stroke. 2015 Oct;10 Suppl A100(Suppl A100):38-45. doi: 10.1111/ijs.12559. Epub 2015 Jun 29. Int J Stroke. 2015. PMID: 26120925 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical